Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Erin Murphy

Vascular Surgery Charlotte, NC Medical Doctor

NPI 1447454210 CMS profile 65276

10660 Park Rd, Ste 3400, Charlotte, NC 28210

Open in the dashboard

General payments

$597,598

736 records reported · program years 2019–2025

Research payments

$16,731

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$314,383 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Erin Murphy of Charlotte, NC is reported in the CMS Open Payments database as having received $597,598 across 736 general payments and $16,731 in research payments paid to them. Separately, studies naming them as principal investigator received $314,383 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $110,634 107
2024 General $154,590 141
2023 General $71,446 128
2023 Research $550 1
2022 General $121,228 153
2021 General $45,528 68
2021 Research $1,125 2
2020 General $48,082 58
2020 Research $11,800 1
2019 General $46,091 81
2019 Research $3,256 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Erin Murphy
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Erin Murphy were reported at $110,634. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Erin Murphy Vascular Surgery median Middle half National median
2019 $46,091 $796 $226–$2,363 $163
2020 $48,082 $348 $118–$1,110 $114
2021 $45,528 $471 $158–$1,421 $132
2022 $121,228 $725 $222–$2,183 $149
2023 $71,446 $836 $257–$2,440 $160
2024 $154,590 $909 $252–$2,619 $164
2025 $110,634 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $205,645 230 payments
  2. Philips Electronics North America Corporation $168,879 157 payments
  3. Boston Scientific Corporation $150,404 130 payments
  4. Cordis US Corp. $21,522 24 payments
  5. Medtronic Vascular, Inc. $20,539 33 payments
  6. Cook Incorporated $12,620 8 payments
  7. Bard Peripheral Vascular, Inc. $6,983 61 payments
  8. W. L. Gore & Associates, Inc. $2,362 24 payments
  9. Inari Medical, Inc. $1,916 2 payments
  10. Cardinal Health 200, LLC $1,500 2 payments
  11. Other $5,228 65 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $261,205 71 payments
  2. Consulting Fee $260,193 97 payments
  3. Honoraria $27,925 10 payments
  4. Food and Beverage $26,479 464 payments
  5. Travel and Lodging $21,667 91 payments
  6. Education $130 3 payments
Products named General payments · program years 2019–2025
  1. Abre $191,691 204 payments
  2. IGT Devices Undivided $57,836 16 payments
  3. (9520) IGT Devices Undivided $47,673 17 payments
  4. IGT D Peripheral $25,354 10 payments
  5. General - Therapies $25,071 11 payments
  6. Spectranetics Undiv $16,440 4 payments
  7. (6554) Peripheral Vascular Undivided $14,070 9 payments
  8. MYNX CONTROL VENOUS $13,385 7 payments
  9. VENASEAL $12,003 7 payments
  10. General - Vascular Intervention $10,615 4 payments
  11. Other $131,421 394 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $15,056 2 payments
  2. Medtronic, Inc. $1,675 3 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Vascular Surgery: 122

Drug cost

$7

Median for Vascular Surgery: $14,135

Branded share of claims

0%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diazepam Generic 12 $7

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$76,940

Medicare's payments for the services billed

Medicare patients

146

Average age 75

Services billed

520

86 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 64%
Ischemic heart disease 32%
Atrial fibrillation 32%
Diabetes 29%
Chronic kidney disease 26%
Heart failure 21%
Cancer 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

741 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record